article_metadata: Oskar Krueger Robin Eisenburger Alpaslan Tasdogan Lisa Zimmer Elisabeth Livingstone Eva Hadaschik Sarah Theurer Berthold Brodin Dirk Schadendorf Selma Ugurel
article_metadata: 10.3389/fimmu.2024.1369190
article_metadata: Front Immunol
article_metadata: 2024 May 14:15:1369190.
article_metadata: checkpoint inhibitors complete response immunotherapy mucosal melanoma neoadjuvant
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38807589/
article_metadata: Ipilimumab / administration & dosage Ipilimumab / therapeutic use Melanoma / drug therapy Melanoma / therapy Neoadjuvant Therapy / methods Nivolumab / administration & dosage Nivolumab / therapeutic use Rectal Neoplasms / drug therapy Rectal Neoplasms / immunology Rectal Neoplasms / pathology Rectal Neoplasms / therapy
article_metadata: Ipilimumab / administration & dosage Ipilimumab / therapeutic use Melanoma / drug therapy Melanoma / therapy Neoadjuvant Therapy / methods Nivolumab / administration & dosage Nivolumab / therapeutic use Rectal Neoplasms / drug therapy Rectal Neoplasms / immunology Rectal Neoplasms / pathology Rectal Neoplasms / therapy Case Reports Antineoplastic Combined Chemotherapy Protocols / therapeutic use Humans Immune Checkpoint Inhibitors / administration & dosage Immune Checkpoint Inhibitors / therapeutic use Immunotherapy / methods Male Middle Aged Treatment Outcome Ipilimumab Nivolumab Immune Checkpoint Inhibitors
article_metadata: PMC11130409
article_metadata: 38807589
article_metadata: Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab
article_metadata: 2024